Literature DB >> 7559404

Identification of dynorphins as endogenous ligands for an opioid receptor-like orphan receptor.

S Zhang1, L Yu.   

Abstract

To identify the endogenous ligands for a cloned orphan receptor that shares high degrees of sequence homology with opioid receptors, this orphan receptor was expressed in Xenopus oocytes and in mammalian cell lines CHO-K1 and HEK-293. The coupling of the receptor to a G protein-activated K+ channel was used as a functional assay in oocytes. Endogenous opioid peptide dynorphins were found to activate the K+ channel by stimulating the orphan receptor. This activation was dose-dependent, with EC50 values at 45 and 37 nM for dynorphin A and dynorphin A-(1-13), respectively. The dynorphin effect was antagonized by the non-selective opioid antagonist naloxone but at rather high concentrations in the micromolar range. Naloxone also caused a rightward shift of the dose-response curve for dynorphin A, suggesting a competitive antagonism mechanism. In transiently transfected cells, 5 microM dynorphin A-(1-13) inhibited the forskolin-stimulated cyclic AMP increase by 51 and 35% in CHO-K1 and HEK-293 cells, respectively. Other classes of endogenous opioids, i.e. enkephalins and endorphins, caused very little activation of this receptor. These results suggest that this orphan receptor is a member of the opioid receptor family and that dynorphins are endogenous ligands for this receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559404     DOI: 10.1074/jbc.270.39.22772

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo.

Authors:  L C Stanfa; V Chapman; N Kerr; A H Dickenson
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 2.  G protein-coupled receptor deorphanizations.

Authors:  Olivier Civelli; Rainer K Reinscheid; Yan Zhang; Zhiwei Wang; Robert Fredriksson; Helgi B Schiöth
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-28       Impact factor: 13.820

3.  Dynorphin peptides: antagonists of melanocortin receptors.

Authors:  J M Quillan; W Sadée
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

4.  Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.

Authors:  M Hiramatsu; K Inoue
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro.

Authors:  M Connor; C W Vaughan; B Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

6.  Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro.

Authors:  C W Vaughan; S L Ingram; M J Christie
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

7.  Pharmacological characterization of inhibitory effects of postsynaptic opioid and cannabinoid receptors on calcium currents in neonatal rat nucleus tractus solitarius.

Authors:  Takayuki Endoh
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

8.  The role of the NOP receptor in regulating food intake, meal pattern, and the excitability of proopiomelanocortin neurons.

Authors:  Borzoo Farhang; Lindsay Pietruszewski; Kabirullah Lutfy; Edward J Wagner
Journal:  Neuropharmacology       Date:  2010-05-25       Impact factor: 5.250

9.  Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones.

Authors:  C W Vaughan; M J Christie
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

10.  Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors.

Authors:  Cynthia Wei-Sheng Lee; Jia-Ying Yan; Yao-Chang Chiang; Tsai-Wei Hung; Hung-Li Wang; Lih-Chu Chiou; Ing-Kang Ho
Journal:  Neurochem Res       Date:  2011-06-14       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.